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Environmental tobacco smoke is a leading environmen-
tal asthma trigger and has been linked to the development
of asthma in children and adults. Smoking cessation and
reduced exposure to secondhand tobacco smoke are key
components of asthma management. We describe a part-
nership involving two state agencies and 14 health plans;
the goal of the partnership was to decrease smoking and
exposure to environmental tobacco smoke among
Medicaid-insured Oregonians with asthma.
Context 
Oregon’s asthma rate is higher than that of the nation-
al population, and approximately one third of Oregonians
with asthma smoke. The Health Promotion and Chronic
Disease Prevention Program (HPCDP) in the Oregon
Department of Human Services has collaborated with
the Office of Medical Assistance Programs (OMAP) to
promote preventive care at the population level.
Methods
Two HPCDP programs — the Oregon Asthma Program
and the Oregon Tobacco Prevention and Education
Program — worked with OMAP to launch the statewide
Asthma–Tobacco Integration Project in 2003. A primary
focus of the project is the development of partnerships
among health plans, health care providers, and large
health care organizations to integrate asthma manage-
ment and smoking control through systems innovations
and provider education. OMAP and its participating
health plans also decided to focus cessation efforts on its
members with chronic diseases. In addition, HPCDP has
collaborated with OMAP to distribute educational tools
and information about tobacco’s impact on asthma mor-
bidity to Oregon’s health care providers who serve low-
income Oregonians.
Consequences
The partnership between OMAP and HPCDP program
staff members has allowed them to discuss problems,
leverage resources, and obtain support for many public
health initiatives. In addition, OMAP–HPCDP collabora-
tion on educational workshops and outreach to health care
providers has helped convince quality improvement spe-
cialists and administrators about the importance of
addressing smoking among patients with asthma. The
Asthma–Tobacco Integration Project has also led to form-
ative research aimed at increasing community involve-
ment in promoting tobacco-free environments.
Interpretation
Collaboration between HPCDP and OMAP has been an
important factor in Oregon’s successful smoking cessation
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efforts in general and in recent efforts to address tobacco
use among Oregonians with asthma.
Background
Asthma is one of the most common chronic diseases in
the United States and has a major impact on the quality of
life of the individuals who have it, as well as on their fam-
ilies, their friends, and society as a whole. Although 
no cure for asthma exists, it can be controlled with 
high-quality medical care and a good self-management
plan, including awareness of asthma triggers and how to
avoid them. Environmental tobacco smoke is a leading
environmental asthma trigger and has been linked to the
development of asthma in children and adults (1,2).
Among people with asthma, cigarette smoking decreases
lung functioning, increases the risk for asthma-related
hospital admissions, increases asthma-related health care
use, and increases the risk of death from asthma (3,4).
Cigarette smoking has also been associated with an
impaired therapeutic response to corticosteroids among
people with chronic asthma (5). Smoking cessation and
reduced exposure to secondhand tobacco smoke are key
components of asthma management.
Many state Medicaid programs shifted from fee-for-serv-
ice systems to predominantly managed care systems in the
1990s, which presented unique opportunities to improve
the public’s health by integrating disease prevention and
public health goals into the health care system (6). In many
situations, managed care led to increased monitoring of
quality of care and in some systems made reimbursement
dependent on performance (7). The Centers for Disease
Control and Prevention (CDC) recognized the potential role
of managed care in implementing population-level disease
prevention activities. The CDC recommended that public
health agencies develop partnerships with Medicaid pro-
grams to identify cost-effective preventive services for
Medicaid populations and hold managed care plans
accountable for the delivery of these services (8,9).
We describe a partnership involving two state agencies
and 14 health plans. The goal of the partnership was 
to decrease smoking and exposure to environmental tobac-
co smoke among Oregonians with asthma who had
Medicaid coverage.
Context
Asthma and smoking among Medicaid-insured individuals
In Oregon, 9.2% of the adult population has asthma,
higher than the national rate of 7.5% (10,11).
Approximately 7.3% of Oregon children have asthma, and
approximately 2500 asthma-related hospitalizations occur
in Oregon each year. Almost 12% of the state’s population
lives on an income less than the poverty threshold, and
442,000 Oregonians (13%) qualify for Medicaid (12).
Among Oregon’s population insured by Medicaid, approxi-
mately 17% of adults report having asthma (13).
Despite the solid evidence that tobacco smoke is detri-
mental to the health of people with asthma, data show
that 31% of Oregon adults with asthma smoke cigarettes,
whereas 23% of Oregon adults without asthma smoke cig-
arettes (14). Among Oregonians insured by Medicaid, the
rate of smoking among adults with asthma is 43% (13).
Oregonians who smoke and have asthma report more
severe asthma symptoms than Oregonians with asthma
who do not smoke. They have more activity limitations,
miss more work and school, and seek urgent medical care
more often (14).
Collaboration between Oregon’s chronic disease programs
and Medicaid
In 1995, the Health Promotion and Chronic Disease
Prevention Program (HPCDP) in the Oregon Department
of Human Services began working with the Office of
Medical Assistance Programs (OMAP), the agency respon-
sible for administering Oregon’s Medicaid programs.
OMAP is the largest purchaser of managed care in Oregon
and has contracts to administer Medicaid with almost all
of the major managed care plans in Oregon. Collaboration
between HPCDP and OMAP helped the agencies promote
preventive care at the population level. Preventive care
interventions developed by HPCDP and OMAP were
offered to Medicaid-insured patients in managed care set-
tings, which in 1995 comprised 85% of the population on
Medicaid and more than a third of Oregon’s overall popu-
lation. In addition, because most health care providers
treated at least some Medicaid patients and belonged to
one of these major health plans, joint OMAP–HPCDP ini-
tiatives had the potential to reach almost all of the pri-
mary care physicians in Oregon.
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exploring potential areas of collaboration between the
agency’s chronic disease programs and major Oregon
health systems. The person in this position works with
health system administrators and data personnel to devel-
op standardized measures of asthma care that can be com-
pared across health systems. HPCDP also provided partial
funding for an OMAP staff position dedicated to develop-
ing and coordinating chronic disease prevention projects of
mutual interest.
The coordinated efforts of the people in the two previ-
ously described positions contributed to the establishment
of a monthly meeting known as the Quality Performance
and Improvement Workgroup. Through this workgroup,
representatives from all the contracted Medicaid health
plans collaborate on prevention activities as part of their
OMAP contract. Activities include implementing physi-
cian trainings, developing quality performance measures
and quality improvement interventions, implementing
tracking systems, developing population-based guidelines,
and developing health care policy and service reforms. This
collaboration helped catalyze a public–private partnership
and a public-health–medical partnership that led to coordi-
nated initiatives promoting chronic disease prevention.
One such initiative was the Tobacco Intervention
Project, a partnership involving HPCDP, OMAP, and
the Tobacco-Free Coalition of Oregon (15). The project
was designed to integrate tobacco-use prevention and
treatment into routine health care. It resulted in the
statewide implementation of a tobacco-cessation 
program by all Medicaid health plans. The program
included counseling and pharmacotherapy, as well as
systematic referral to the Oregon Tobacco Quit Line.
The program also included an evaluation component
so that health plans could conduct patient satisfaction
surveys and chart audits, review relevant administra-
tive claims data to assess the program’s effects, and
obtain data on numbers of Oregon Tobacco Quit Line
calls received from their members. Health plan staff
members conducted training and outreach programs
for their physicians and provided education and out-
reach programs to members through mass mailings
and other forms of communication (15). These initial
collaborative projects have led to several more recent




Two HPCDP programs — the Oregon Asthma Program
and the Oregon Tobacco Prevention and Education
Program — began the statewide Asthma–Tobacco
Integration Project in 2003. The goal of the project is to
reduce smoking prevalence and secondhand smoke expo-
sure among people with asthma. A primary focus of the
project is the development of partnerships among health
plans, health care providers, and large health care organi-
zations to integrate asthma management and smoking con-
trol through systems innovations and provider education.
One of the strategies for implementing the
Asthma–Tobacco Integration Project was to leverage
OMAP’s investment in tobacco cessation by dedicating
HPCDP staff to support OMAP–HPCDP cooperation on
asthma management projects, a strategy that had been
used previously to promote tobacco cessation. However,
because of budget constraints and a hiring freeze, HPCDP
was not able to hire new employees. Instead, the state asth-
ma and tobacco programs successfully applied to the CDC’s
Public Health Prevention Service for a staff member to fill
this role. The program sends master’s-level, CDC-trained
prevention specialists with backgrounds in program man-
agement and epidemiology to state and local health depart-
ments. This new staff person’s duties involve coordination
not only between HPCDP’s asthma program and tobacco
program but also between HPCDP and OMAP.
Discussions between HPCDP and OMAP produced addi-
tional tobacco-cessation initiatives at the health systems
level. Building on the infrastructure established by the
Tobacco Intervention Project, OMAP and its participating
health plans decided to target cessation efforts toward its
members with chronic diseases. In addition, the health
plans in OMAP chose asthma management as a key per-
formance measure for the 2004–2005 fiscal year, partly
because of the existence of asthma quality performance
indicators developed through a cooperative effort between
HPCDP and Oregon’s major health plans.
As part of the Asthma–Tobacco Integration Project,
HPCDP and OMAP have distributed educational tools and
information about tobacco’s impact on asthma morbidity
to almost all of Oregon’s health care providers who serve
low-income Oregonians. In April 2004, HPCDP distributed
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a report on tobacco and asthma in the CD Summary, an
epidemiology newsletter that is produced semimonthly by
the Oregon Department of Human Services and sent to all
physicians and nurse practitioners in Oregon. The report,
“Tobacco and Asthma — Enough to Take Your Breath
Away,” discussed the epidemiology of tobacco use among
adults with asthma and provided effective clinical inter-
ventions and resources for clinicians (16).
As part of another Asthma–Tobacco Integration Project
activity, HPCDP and OMAP staff collaborated to plan and
conduct a statewide workshop on asthma management
issues for medical directors and quality improvement
managers from Medicaid health plans. Such workshops
are held twice a year by OMAP. Topics are selected by the
OMAP Quality Performance and Improvement
Workgroup participants with the purpose of enhancing
health plan initiatives. The day-long statewide workshop
was called “What Does Good Asthma Care Look Like? The
Roles of Health Plans and Providers.” Topics included best
practices and guidelines that promote high-quality asthma
care and the roles of providers, health plans, and the pub-
lic health field in improving population-level asthma care.
The workshop included a speech from a national expert on
health system strategies to promote effective asthma 
management, as well as an expert panel comprised of 
proponents of asthma-related disease registries, disease
management, and other successful asthma-related inter-
ventions at the health systems level. The importance of
systematically assessing and treating tobacco use in clini-
cal settings was emphasized throughout. Clinical asthma
and tobacco tools were provided to medical directors and
quality improvement coordinators.
Additional performance improvement interventions
The activities described have led to additional collabora-
tive initiatives to educate and empower health providers
and health systems about tobacco control and asthma
care. In July 2005, 14 health plans began using an asthma
registry (created through a joint effort between 
HPCDP and the participating health systems) to conduct
smoking-cessation activities for members with asthma.
The outreach effort involves distribution of materials 
(previously tested by focus groups) to encourage members
who smoke and have asthma to quit, as well as to encour-
age quitting among plan members who smoke and care for
a household member with asthma. The distributed mate-
rials contain information about the effects of tobacco
smoke on people with asthma, tobacco-cessation assis-
tance, and information about the Oregon Tobacco Quit
Line. Health plans are also promoting the Oregon Asthma
Resource Bank, a clinically accurate, patient-tested Web
site that contains free, easy-to-read, and culturally appro-
priate asthma education and clinical management tools
developed by asthma experts in Oregon.
Consequences
The partnership between OMAP and HPCDP program
staff members has allowed them to discuss problems,
leverage resources, and obtain support for many public
health initiatives. Despite competing priorities and limit-
ed resources, collaboration between the two agencies has
allowed each of them to accomplish more in the area of
smoking and asthma than either could have alone. Initial
partnerships promoting smoking cessation served as a
model for the Asthma–Tobacco Integration Project.
Partly as a result of the Asthma–Tobacco Integration
Project and other initial programs, 80% of the Oregon
Medicaid plans have implemented tobacco-related policy
and planning, quality improvement programs, communi-
cation initiatives, and clinical delivery systems; 50% of the
dental care organizations have done the same.
OMAP–HPCDP collaboration on educational workshops
and outreach to health care providers has helped convince
quality improvement specialists and administrators about
the importance of addressing smoking among patients
with asthma. More than 60 people attended the statewide
Quality Improvement Workgroup on asthma. All 14
Medicaid health plans were represented, including two
Medicaid dental health plans. In previous years, such
workshops were attended primarily by quality improve-
ment managers and medical directors, but because of
OMAP’s collaboration with HPCDP’s asthma program, the
workshop’s participants also included local public health
specialists, clinicians, pharmacists, and education special-
ists. Survey results from the workshop revealed that more
than 95% of the respondents either strongly agreed or
agreed that the information presented would be useful in
their work. Furthermore, 90% of the respondents 
appreciated the opportunity to network with members of
other health plans and public health programs, share best
practices, and learn about other interventions to improve
the quality of asthma care.
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Project information to clinicians has had positive results.
After HPCDP released its CD Summary newsletter on
tobacco’s impact on people with asthma, several health
plans used information from the publication in their own
health plan newsletters (16).
The Asthma–Tobacco Integration Project has also led to
formative research aimed at increasing community
involvement in promoting tobacco-free environments.
HPCDP has conducted a series of focus groups among pop-
ulations with a high smoking prevalence (including vari-
ous racial and ethnic groups and low socioeconomic status
groups) to identify smoking-cessation messages that 
motivate and are relevant to these populations. Additional
populations considered priorities for focus groups include
people with asthma who smoke and people who smoke and
have a child with asthma. Several health plans helped
recruit their members to become focus group participants.
The information will be used in targeted media campaigns
and other interventions to generate grassroots support for
tobacco-cessation and prevention programs.
Interpretation
Collaboration between HPCDP and OMAP has been an
important factor in Oregon’s successful smoking cessation
efforts in general and in recent efforts to address tobacco
use among Oregonians with asthma. Initiatives have been
greatly enhanced by the staff positions that were devel-
oped to establish and expand collaboration between
HPCDP and OMAP and between HPCDP and major
health plans. In addition, the collaboration between the
two agencies has been driven by a clear common interest:
for humanitarian and economic reasons, OMAP has been
motivated to decrease smoking prevalence among people
with asthma and other chronic diseases — one of the core
missions of HPCDP.
The partnership between public health professionals
and the administrators and directors of Oregon’s Medicaid
plans has helped maintain the Medicaid program’s focus
on chronic disease prevention. In addition, cooperation
between public health professionals and OMAP provides
an extensive network through which HPCDP can distrib-
ute educational tools and messages regarding smoking
cessation and chronic disease management to physicians
and nurse practitioners throughout Oregon. Additional
process and outcome evaluations to assess the effective-
ness of recent partnership activities addressing tobacco
use and asthma are currently in progress.
The monthly OMAP Quality Performance and
Improvement Workgroup has been an effective forum
through which HPCDP and OMAP can collaborate with
health plans and optimize use of resources and staff time.
Public health professionals provide expert information on
epidemiology, surveillance, and health promotion program
planning. OMAP and the participating health plans serve
as leaders and provide the practical knowledge that makes
it possible to translate the objectives of an intervention
such as the Asthma–Tobacco Integration Project into func-
tional clinical systems. In addition, OMAP encourages
health plans and health care practitioners to be account-
able for promoting high-quality care.
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